# Processa Pharmaceuticals, Inc.: Form D filings

Processa Pharmaceuticals, Inc., a pharmaceuticals company in Hanover, MD, filed 16 Form D notices with the SEC between 2011 and 2021. The latest, on February 19, 2021, reports $10.2 million sold of a $10.2 million offering to 18 investors.

Find out what Processa Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Processa%20Pharmaceuticals%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Processa%20Pharmaceuticals%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fprocessa-pharmaceuticals-inc-1533743)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Processa%20Pharmaceuticals%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Processa%20Pharmaceuticals%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fprocessa-pharmaceuticals-inc-1533743)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Maryland](https://specstream.ai/data/form-d/state/maryland): 608 rows, by operating companies, filed since November 1, 2024, $30.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/maryland
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 7380 COCA COLA DRIVE, SUITE 106, Hanover, MD, 21076
- Phone: (443) 776-3133
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1533743

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Feb 19, 2021 | New notice | $10,238,773 | $10,238,773 | $0 | 18 | Feb 16, 2021 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1533743/000089706921000105/0000897069-21-000105-index.htm) |
| May 16, 2018 | New notice | $8,000,000 | $2,525,694 | $5,474,306 | 33 | May 15, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1533743/000089706918000366/0000897069-18-000366-index.htm) |
| Dec 27, 2017 | Amendment | $2,580,000 | $2,580,000 | $0 | 23 | Oct 4, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1533743/000089706917000599/0000897069-17-000599-index.htm) |
| Dec 5, 2017 | New notice | $2,580,000 | $2,580,000 | $0 | 23 | Oct 4, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1533743/000139390517000386/0001393905-17-000386-index.htm) |
| Mar 24, 2015 | New notice | $25,500 | $25,500 | $0 | 3 | Mar 24, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1533743/000144155715000007/0001441557-15-000007-index.htm) |
| Feb 20, 2015 | New notice | $2,000,000 | $90,000 | $1,910,000 | 3 | Feb 5, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1533743/000144155715000003/0001441557-15-000003-index.htm) |
| Nov 13, 2014 | New notice | $75,000 | $75,000 | $0 | 1 | Oct 9, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1533743/000144155714000054/0001441557-14-000054-index.htm) |
| Oct 27, 2014 | New notice | $6,388,912 | $173,825 | $6,215,087 | 15 | Oct 6, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1533743/000144155714000049/0001441557-14-000049-index.htm) |
| Jan 13, 2014 | New notice | $175,000 | $175,000 | $0 | 6 | Jan 8, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1533743/000144155714000003/0001441557-14-000003-index.htm) |
| Jan 10, 2014 | New notice | $1,000,000 | $250,000 | $750,000 | 1 | Jan 6, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1533743/000144155714000002/0001441557-14-000002-index.htm) |
| Sep 30, 2013 | Amendment | $4,950,000 | $2,182,944 | $2,767,056 | 51 | Jul 15, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1533743/000144155713000078/0001441557-13-000078-index.htm) |
| Jul 12, 2013 | New notice | $5,400,000 | $0 | $5,400,000 | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1533743/000144155713000063/0001441557-13-000063-index.htm) |
| Jun 24, 2013 | New notice | $4,500,000 | $0 | $4,500,000 | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1533743/000144155713000046/0001441557-13-000046-index.htm) |
| May 28, 2013 | New notice | $1,000,000 | $1,000,000 | $0 | 7 | May 22, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1533743/000144155713000043/0001441557-13-000043-index.htm) |
| Aug 10, 2012 | New notice | $1,520,000 | $1,520,000 | $0 | 44 | Aug 6, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1533743/000153374312000003/0001533743-12-000003-index.htm) |
| Oct 28, 2011 | New notice | $3,000,000 | $0 | $3,000,000 | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1533743/000153374311000001/0001533743-11-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| David Young | Executive Officer, Director |  |
| Patrick Lin | Executive Officer |  |
| Justin W. Yorke | Director |  |
| Virgil W. Thompson | Director |  |
| Michael W. Floyd | Executive Officer |  |
| Wendy W. Guy | Executive Officer |  |
| Khalid W. Islam | Director |  |
| Geraldine W. Pannu | Director |  |
| James W. Stanker | Executive Officer |  |
| Sian W. Bigora | Executive Officer |  |

[Every Form D from the week of Feb 15, 2021](https://specstream.ai/data/form-d/week/2021-02-15) · [All recent filings in Maryland](https://specstream.ai/data/form-d/state/maryland) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Processa Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).